Publicity and the FDA, An Update

DSpace/Manakin Repository

. . . . . .

Title:	Publicity and the FDA, An Update
Author:	Johnson, Shannon E.
Citation:	Publicity and the FDA, An Update (1997 Third Year Paper)
Full Text & Related Files:	sjohnson.pdf (176.0Kb; PDF) sjohnson.rtf (44.62Kb; RTF file) sjohnson.html (56.04Kb; HTML)
Abstract:	Publicity is a powerful tool. A single Food and Drug Administration (FDA) press release announcing the dangers of a product can instantaneously alter the consumption patterns of millions of consumers. During the early 1970's, the FDA's use of publicity became the subject of heightened scrutiny by legal scholars and practitioners, calling for guidelines and judicial review to prevent unwarranted damage from the potent instrument. This paper will reexamine the FDA's use of publicity in light of the past 20 years. Following a general background, the discussion will update the status of agency policy and judicial attitudes towards publicity, highlight current implications, and offer recommendations.
Terms of Use:	This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page:	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846783